Evidence mapPaperPMID 41545741Full record

ReviewNature reviews. Neurology2026

The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process.

Harriet Demnitz-King, Sube Banerjee, Claudia Cooper, Charlotte Kenten, Rosemary Phillips, Sedigheh Zabihi, Yvonne Birks, Carol Brayne, Sallyann Browning, Camille Carroll and 32 more

Abstract readReviewConsensus Statement
PubMed Publisher
In one paragraph

Review in Nature reviews. Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. From mapping evidence to engaging voices: Paving the way for research on the social determinants of dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Harriet Demnitz-KingCentre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University, London, UK. h.demnitz-king@qmul.ac.uk.ORCID 0000-0002-7421-7101
Sube BanerjeeFaculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Claudia CooperCentre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University, London, UK.ORCID 0000-0002-2777-7616
Charlotte KentenCentre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University, London, UK.ORCID 0000-0001-7012-7347
Rosemary PhillipsDeNPRU-QM Patient and Public Engagement Group, London, UK.
Sedigheh ZabihiCentre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University, London, UK.
Yvonne BirksOlder Adults' Social Care (OSCaR) Group, School for Business and Society, University of York, York, UK.ORCID 0000-0002-4235-5307
Carol BrayneDepartment of Psychiatry, Cambridge Public Health, University of Cambridge, Cambridge, UK.ORCID 0000-0001-5307-663X
Sallyann BrowningDeNPRU-QM Patient and Public Engagement Group, London, UK.
Camille CarrollTranslational and Clinical Research Institute, Newcastle University, Newcastle, UK.ORCID 0000-0001-7472-953X
Georgina CharlesworthUCL Unit for Stigma Research (UCLUS), Clinical, Educational and Heath Psychology, Psychology and Language Sciences, University College London, London, UK.ORCID 0000-0002-5278-1756
Carol Ac CouplandCentre for Academic Primary Care, School of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0002-2327-3306
Tom DeningInstitute of Mental Health, University of Nottingham, Nottingham, UK.ORCID 0000-0003-3387-4241
Ruth DobsonCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University, London, UK.ORCID 0000-0002-2993-585X
Isabelle F FooteCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University, London, UK.
Sarah FosterAlzheimer's Research UK, Cambridge, UK.ORCID 0009-0004-2086-0005
Chris FoxUniversity of Exeter Medical School, Exeter, UK.
Robert HowardDivision of Psychiatry, University College London, London, UK.
Jeremy D IsaacsDepartment of Neurology, St George's University Hospitals NHS Foundation Trust, London, UK.
Uzma JaffryAlzheimer's Research UK, Cambridge, UK.
Ivan KoychevDepartment of Brain Sciences, Imperial College London, London, UK.
Gill LivingstonDivision of Psychiatry, University College London, London, UK.ORCID 0000-0001-6741-5516
David J LlewellynCentre for Academic Primary Care, School of Medicine, University of Nottingham, Nottingham, UK.
Richard OakleyAlzheimer's Society, London, UK.
Magdalena Opazo BretónUnit of Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0002-1226-7541
Martin OrrellInstitute of Mental Health, University of Nottingham, Nottingham, UK.ORCID 0000-0002-1169-3530
Alastair J NoyceCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University, London, UK.
Tommy PounceyDeNPRU-QM Patient and Public Engagement Group, London, UK.
Greta RaitResearch Department of Primary Care and Population Health, University College London, London, UK.ORCID 0000-0002-7216-7294
Janice RansonUniversity of Exeter Medical School, Exeter, UK.
Mohammed RaufDeNPRU-QM Patient and Public Engagement Group, London, UK.
Vanessa RaymontDepartment of Psychiatry, University of Oxford, Oxford, UK.
Elizabeth L SampsonCentre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University, London, UK.
Jonathan M SchottDementia Research Centre, Queen Square Institute of Neurology, University College London, London, UK.ORCID 0000-0003-2059-024X
Debs SmithDeNPRU-QM Patient and Public Engagement Group, London, UK.
Xin You TaiNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Alison ThomsonCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University, London, UK.ORCID 0000-0002-9299-0130
Sebastian WalshDepartment of Psychiatry, Cambridge Public Health, University of Cambridge, Cambridge, UK.
Dylan M WilliamsDivision of Psychiatry, University College London, London, UK.ORCID 0000-0002-3825-2487
Naaheed MukadamDivision of Psychiatry, University College London, London, UK.
Charles R MarshallCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University, London, UK. charles.marshall@qmul.ac.uk.ORCID 0000-0002-8227-2354
National Institute of Health and Care Research Policy Research Unit in Dementia and Neurodegeneration at Queen Mary University of London (DeNPRU-QM)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Translation of evidence about dementia risk and its reduction into effective, equitable public health policy is a major challenge. To address this challenge, the National Institute for Health and Care Research Policy Research Unit in Dementia and Neurodegeneration at Queen Mary University of London (DeNPRU-QM) convened a multidisciplinary panel of 40 experts from across England, with diverse lived, academic, clinical, policy and advocacy experience, at various career stages, and of diverse gender and ethnicity, to develop actionable policy recommendations for dementia risk reduction. Through a 2-day in-person workshop and a subsequent three-round modified Delphi survey, the panel evaluated and refined statements on dementia prevention. The panel achieved consensus on 56 recommendations in four domains: public health messaging, individual-level interventions, population-level interventions and research commissioning. A key priority across all domains was the need to consider and address health inequalities so that prevention efforts do not exacerbate existing disparities. Our recommendations provide policymakers with a robust foundation for designing and implementing an evidence-based dementia prevention strategy in England and provide guidance that can inform approaches in other countries and contexts. By prioritizing clear communication, targeted intervention and sustained research investment, the recommendations can help to address structural inequities and advance dementia risk reduction. Ongoing cross-sector advocacy will be crucial in driving policy adoption and implementation.

Indexed as

Delphi TechniqueDementiaHealth PolicyRisk Reduction BehaviorEnglandHumans

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.